Tohoku University, School of Medicine, Sendai, Japan.
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway; NKS Olaviken Gerontopsychiatric Hospital, Bergen, Norway.
Pain Manag Nurs. 2021 Jun;22(3):319-326. doi: 10.1016/j.pmn.2020.11.014. Epub 2021 Jan 8.
Between 40%-60% of nursing home patients with dementia suffer from chronic and acute pain despite increasing their analgesic drug prescription.
Determine the locations and intensity of pain and the association between quality of life (QoL) and four stratified pain-analgesic groups: (1) pain-analgesics treatment; (2) pain-no analgesics; (3) no pain-analgesics treatment; and (4) no pain-no analgesics.
Multicenter, multicomponent cluster randomized controlled Communication, Systematic assessment and treatment of pain, Medication review, Occupational therapy, and Safety - an effectiveness (COSMOS) trial.
At baseline, 723 nursing home patients were enrolled; 463 were completely evaluated for the presence of pain and included in the cross-sectional analyses.
Data were collected using the following tests: Cognitive function (Mini-Mental-State Evaluation [MMSE]); Quality of Life in Late stage of Dementia (QUALID); Dementia-Specific QoL (QUALIDEM); Mobilization-Observation-Behavior-Intensity-Dementia Pain Scale (MOBID-2); and number of analgesic drug prescriptions. Analysis of covariance (ANCOVA) was used to compare pain and QoL across pain-analgesics groups.
The majority of participants (78%) had moderate-to-severe dementia, were female (74%), and a mean age of 86.7 years. Almost 44% reported clinically significant pain, whereas 69% had ≥2 pain locations, especially in the musculoskeletal system. Some 33.5% of participants had pain receiving analgesics, 10% had pain with no analgesics, and 27% had no pain receiving analgesics. Patients evaluated with clinically significant pain intensity scores had lower QoL (<.001) compared with assessments relying on different pain locations.
Untreated musculoskeletal and multi-located pain is still common in nursing home patients with dementia. A significant share without pain receive analgesics. Proper pain assessment and regular re-assessment are prerequisites for the prescribing and deprescribing of analgesics. Pain intensity scores are more significantly connected to QoL. This must be stressed when evaluating pain and QoL.
尽管增加了镇痛药物的处方,但仍有 40%-60%的痴呆养老院患者患有慢性和急性疼痛。
确定疼痛的位置和强度,以及生活质量(QoL)与四个分层疼痛镇痛组之间的关系:(1)疼痛镇痛治疗;(2)疼痛无镇痛;(3)无疼痛镇痛治疗;(4)无疼痛无镇痛。
多中心、多成分聚类随机对照通信、系统评估和疼痛治疗、药物审查、职业治疗和安全 - 有效性(COSMOS)试验。
在基线时,招募了 723 名养老院患者;463 名患者完全评估了疼痛的存在,并纳入了横断面分析。
使用以下测试收集数据:认知功能(简易精神状态评估[MMSE]);晚期痴呆症的生活质量(QUALID);痴呆症特异性 QoL(QUALIDEM);移动观察行为强度痴呆症疼痛量表(MOBID-2);和镇痛药处方数量。使用协方差分析(ANCOVA)比较疼痛和 QoL 在疼痛镇痛组之间的差异。
大多数参与者(78%)患有中度至重度痴呆症,女性(74%),平均年龄为 86.7 岁。近 44%的人报告有临床显著疼痛,而 69%的人有≥2 个疼痛部位,特别是在肌肉骨骼系统。约 33.5%的接受镇痛治疗的患者有疼痛,10%的患者有疼痛但没有镇痛治疗,27%的患者没有疼痛但接受镇痛治疗。评估为疼痛强度评分有临床意义的患者的 QoL 较低(<.001)与依赖不同疼痛部位的评估相比。
痴呆养老院患者中仍然普遍存在未经治疗的肌肉骨骼和多部位疼痛。相当一部分没有疼痛的患者接受了镇痛治疗。适当的疼痛评估和定期重新评估是开处和停止镇痛药的前提。疼痛强度评分与 QoL 的相关性更为显著。在评估疼痛和 QoL 时,这一点必须强调。